These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34623618)

  • 1. Effectiveness and safety of rehabilitation on minimal change nephrotic syndrome in remission for elderly patients with low activity of daily living: a case report.
    Takahashi R; Yabe H; Hibino T; Morishita S; Ishikawa H
    CEN Case Rep; 2022 May; 11(2):196-202. PubMed ID: 34623618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rehabilitation of a Patient With Minimal Change Nephrotic Syndrome and Acute Kidney Injury: A Case Report.
    Hirano Y; Kono K; Yamauchi K; Yasuda H
    J UOEH; 2022; 44(3):257-262. PubMed ID: 36089343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent minimal change nephrotic syndrome and type 1 diabetes mellitus in an adult Japanese woman: a case report.
    Nishizono R; Kogou H; Ishizaki Y; Minakawa A; Kikuchi M; Inagaki H; Sato Y; Fujimoto S
    BMC Nephrol; 2020 Sep; 21(1):410. PubMed ID: 32967631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous remission of minimal change nephrotic syndrome in an elderly man.
    Chiba Y; Nagasawa T; Kin S; Takahashi K; Yoshida M; Oe Y; Okamoto K; Sato H; Miyazaki M
    CEN Case Rep; 2021 May; 10(2):301-307. PubMed ID: 33398783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
    Yoshimoto K; Wada T; Iwata Y; Sakai N; Shimizu M; Furuichi K; Yokoyama H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):640-3. PubMed ID: 11195400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal change nephrotic syndrome with Guillain-Barré syndrome.
    Ilyas M; Tolaymat A
    Pediatr Nephrol; 2004 Jan; 19(1):105-6. PubMed ID: 14648330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of minimal change nephrotic syndrome with pregnancy.
    Horigome M; Kobayashi R; Hanaoka M; Kinguchi S; Kanaoka T; Toya Y; Wakui H; Tamura K
    CEN Case Rep; 2021 Aug; 10(3):315-319. PubMed ID: 33405175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].
    Pruna A; Barka A; Nochy D; Hauet T; Boulanger H; Landais P
    Nephrologie; 1997; 18(3):95-101. PubMed ID: 9297136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults.
    Oniszczuk J; Beldi-Ferchiou A; Audureau E; Azzaoui I; Molinier-Frenkel V; Frontera V; Karras A; Moktefi A; Pillebout E; Zaidan M; El Karoui K; Delfau-Larue MH; Hénique C; Ollero M; Sahali D; Mahévas M; Audard V
    Nephrol Dial Transplant; 2021 Mar; 36(4):609-617. PubMed ID: 33241414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous remission of adult-onset minimal change nephrotic syndrome associated with influenza B infection: a case report.
    Haruki A; Ishikawa E; Katayama K; Ito T; Hiramoto T; Fujimoto M; Murata T; Ito M
    BMC Nephrol; 2018 Jul; 19(1):162. PubMed ID: 29973143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotic syndrome due to minimal-change disease superimposed on anti-glomerular basement membrane antibody positive glomerulonephritis; a case report.
    Shibata Y; Fukuoka K; Yokota R; Lee H; Sayo H; Ikegaya N; Mori K; Yamamoto J; Isomura A; Nagahama K; Shimoyamada H; Kawakami T; Komagata Y; Kaname S
    BMC Nephrol; 2020 Jul; 21(1):283. PubMed ID: 32680573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure associated with minimal change nephrotic syndrome in an elderly adult.
    Morita A; Ishimura E; Tabata T; Shoji S; Inoue T; Nishizawa Y; Morii H
    Osaka City Med J; 1994 Jul; 40(1):37-42. PubMed ID: 9309942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relapsing nephrotic syndrome in a diabetic patient with minimal change].
    García Donaire JA; Manzanera MI; Valentín MO; Espejo B; Gutiérrez Martínez E; Praga M
    Nefrologia; 2004; 24(2):179-82. PubMed ID: 15219093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy.
    Kobayashi T; Ando Y; Umino T; Miyata Y; Muto S; Hironaka M; Asano Y; Kusano E
    Clin Nephrol; 2006 Jun; 65(6):423-6. PubMed ID: 16792138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases.
    Arrestier R; Satie AP; Zhang SY; Plaisier E; Isnard-Bagnis C; Gatault P; Raimbourg Q; Buob D; Vocila F; Heng AE; Francois H; Moktefi A; Canaud G; Matignon M; Dejucq-Rainsford N; Brocheriou I; Sahali D; Audard V
    BMC Nephrol; 2018 Nov; 19(1):331. PubMed ID: 30458703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MCNS, which secondary developed into incidental IgA nephropathy--a case report].
    Tsunehisa N; Takemura T; Inui T; Kamiya H
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1095-9. PubMed ID: 1289609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria.
    Tanaka M; Furuhashi M; Moniwa N; Maeda T; Takizawa H; Matsumoto M; Sakai A; Higashiura Y; Gocho Y; Koyama M; Ogawa Y; Miura T
    BMC Nephrol; 2020 Nov; 21(1):459. PubMed ID: 33143633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
    Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
    Am J Nephrol; 2000; 20(3):175-9. PubMed ID: 10878397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.